Moderna ( NASDAQ: MRNA) Q4 2024 Earnings Conference Call February 14, 2025 8:00 AM ET Lavina Talukdar - Senior Vice President, Investor Relations Stephane Bancel - Chief Executive Officer Jamey Mock - ...

Q4 2024 Results Conference Call February 13, 2025 11:00 AM ETCompany ParticipantsDan Cuthbertson - Director, IRDean Setoguchi ...

In an era where technological advancements are constantly reshaping the landscape of the pharmaceutical industry, Protheragen-ING has emerged as a frontrunner with its cutting-edge AI-synthesizer for ...

Alzheimer's disease is at the center of a revolutionary theory in neuroscience, where the mysteries of the human brain ...

Q4 2024 Earnings Call Transcript February 13, 2025 Operator: Good morning, ladies and gentlemen, and welcome to the Trinseo ...

Astrophysicists have unearthed a surprising diversity in the ways in which white dwarf stars explode in deep space after assessing almost 4,000 such events captured in detail by a next-gen ...

Prof. Dan Shechtman of the Technion–Israel Institute of Technology made the discovery that would later earn him the 2011 ...

Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.This report on Uranium provides comprehensive ...

Russia's state-owned Rosatom announced a prototype plasma engine which could speed up travel to other planets.

Tokyo, Japan and Cambridge, UK, 14 February 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) provides an update on operational activities and reports its consolidated results for the ...

First Major Technological Breakthrough in Hyaluronic Acid Dermal Fillers in a Decade; U.S. Launch Planned in Q2 2025 ...

In December 2024, the Company announced a strategic restructuring of its business operations, including the potential divestiture of its DNA Tagging and Security Products and Services ("DNA Tagging") ...